Inveltys

Chickenpox, Iritis, Inflammation + 10 more

Treatment

14 FDA approvals

20 Active Studies for Inveltys

What is Inveltys

Loteprednol

The Generic name of this drug

Alrex

is the brand name

image of different drug pills on a surface

Inveltys Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Alrex

Loteprednol

1998

16

Approved as Treatment by the FDA

Loteprednol, otherwise called Alrex, is approved by the FDA for 14 uses like Ocular Inflammation and ocular bacterial infections .

Ocular Inflammation

ocular bacterial infections

Used to treat ocular bacterial infections in combination with Tobramycin

Iritis

Inflammation

Used to treat Inflammation in combination with Tobramycin

Conjunctivitis infective

Seasonal Allergic Conjunctivitis

Conjunctivitis

Herpes Zoster Keratitis

Helps manage Herpes Zoster Keratitis

Inflammation

Used to treat Inflammation in combination with Tobramycin

Conjunctivitis

Iritis

Eye

Cyclitis

Superficial punctate keratitis

Helps manage Superficial punctate keratitis

When to interrupt dosage

The recommended measure of Inveltys is contingent upon the ascertained condition, including Ocular Inflammation, Conjunctivitis infective and Herpes Zoster Keratitis. The quantity of dosage shifts, as per the technique of delivery (e.g. Gel - Ophthalmic or Suspension/drops) noted in the table beneath.

Condition

Dosage

Administration

Inflammation

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Rosacea

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Conjunctivitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Conjunctivitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Cyclitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Eye

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Chickenpox

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Communicable Diseases

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Superficial punctate keratitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

ocular bacterial infections

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Iritis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Seasonal Allergic Conjunctivitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Herpes Zoster Keratitis

, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %

Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, , Ointment - Ophthalmic, Ointment, Suspension - Ophthalmic, Gel, Gel - Ophthalmic, Suspension

Warnings

Inveltys Contraindications

Condition

Risk Level

Notes

Keratitis, Dendritic

Do Not Combine

conjunctiva

Do Not Combine

Herpes Simplex

Do Not Combine

Chickenpox

Do Not Combine

Vaccinia

Do Not Combine

epithelial herpes simplex keratitis

Do Not Combine

Eye Infections, Fungal

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Loteprednol may interact with Pulse Frequency

There are 20 known major drug interactions with Inveltys.

Common Inveltys Drug Interactions

Drug Name

Risk Level

Description

2,4-thiazolidinedione

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with 2,4-thiazolidinedione.

AICA ribonucleotide

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with AICA ribonucleotide.

AMG-222

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with AMG-222.

Acarbose

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Acarbose.

Acetohexamide

Moderate

The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Acetohexamide.

image of a doctor in a lab doing drug, clinical research

Inveltys Novel Uses: Which Conditions Have a Clinical Trial Featuring Inveltys?

198 active clinical trials are currently in progress to ascertain the efficacy of Inveltys in alleviating Seasonal Allergic Conjunctivitis, Iritis and Ocular Inflammation.

Condition

Clinical Trials

Trial Phases

Eye

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Superficial punctate keratitis

0 Actively Recruiting

Iritis

0 Actively Recruiting

Herpes Zoster Keratitis

0 Actively Recruiting

Rosacea

2 Actively Recruiting

Early Phase 1, Phase 2

Conjunctivitis

0 Actively Recruiting

ocular bacterial infections

0 Actively Recruiting

Chickenpox

3 Actively Recruiting

Phase 3

Cyclitis

0 Actively Recruiting

Inflammation

54 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 3, Phase 4

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Inveltys Reviews: What are patients saying about Inveltys?

5

Patient Review

2/7/2020

Inveltys for Inflammation of the Eye Following Surgery

I've been using these eye drops for months, first for post-surgery and later for my dry eye. Applying them twice daily really helped with the swelling and vision. I also found that I didn't have to rub my eyes as much when using inveltys which was a huge plus.

4.3

Patient Review

8/2/2021

Inveltys for Inflammation of the Eye Following Surgery

I'm a few weeks out from surgery and my eyes feel much more relaxed. I tried another product previously that was in gel form, but it felt really uncomfortable. This one works better for me. It's a little pricy, but it's worth trying.

2.3

Patient Review

8/29/2022

Inveltys for Inflammation of the Eye Following Surgery

I wasn't a fan of this bottle. It wasted a lot of product and was difficult to use.

2

Patient Review

5/9/2019

Inveltys for Inflammation of the Eye Following Surgery

surgery was two weeks ago and my eyes are still swollen. Not only that, but my vision has become cloudy. I don't see the appeal of this drug at all.

2

Patient Review

5/17/2020

Inveltys for Inflammation of the Eye Following Surgery

I'm using this medication for the inflammation of my retina following cataract surgery, but I have yet to see any improvement. It's a very expensive drug with little to show for it so far.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about inveltys

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is another name for Inveltys?

"Only for ophthalmic use.

Inveltys is an eye drop that contains a steroid. It is used to treat inflammation."

Answered by AI

What are the side effects of Inveltys eye drops?

"The following are symptoms of eye allergies: headaches, burning, eye irritation, itching, dry eyes, blurred eyesight, feeling that something is in the eye, runny nose."

Answered by AI

How long should you use Inveltys after cataract surgery?

"Apply one or two drops of the solution into the affected eye up to four times a day, starting 24 hours after the surgery was performed. Continue using the solution for two weeks."

Answered by AI

What does Inveltys do for the eye?

"Inveltys is a steroid eye drop used to treat inflammation caused by allergies, shingles, severe acne, iritis, or other conditions. It can also help relieve pain and swelling after eye surgery."

Answered by AI

Clinical Trials for Inveltys

Image of Montana State University in Bozeman, United States.

Haskap Berries for Exercise Performance Recovery

18 - 35
All Sexes
Bozeman, MT

The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following: * Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults? * Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults? * The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance. * Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet * Participants will perform an intense resistance workout * Participants will have their blood drawn before and after the workout * Performance will be analyzed at 24, 48 and 72 hours after the workout

Recruiting
Paid Trial

Montana State University

Mary P Miles

Image of University of New Brunswick in Fredericton, Canada.

Mediterranean Diet for Toddler Health

24 - 36
All Sexes
Fredericton, Canada

Toddlerhood (ages 2-3) is a critical window when the gut microbiome is still developing and eating habits are being established. Yet, many Canadian toddlers eat diets high in sugar and salt, which may affect long-term health. This study will test whether a MED diet can improve dietary inflammation, gut health, and body composition in toddlers and whether a tailored nutrition education program for parents can help families maintain healthy eating patterns. In this study, toddlers will be randomly assigned to a 3-week MED diet or their usual diet. Families in the MED diet group will receive free meal boxes for the 3 weeks, plus guidance from a nutrition researcher through a structured education program. The standard diet group will continue their regular diet with general nutrition advice. Researchers will collect dietary information, body composition assessments, and stool samples to measure gut microbiome composition and metabolites. This first study of a controlled diet intervention in toddlers, combining behavioral support, high-quality food provision, and advanced gut microbiome analysis, will help understand how early diet shapes lifelong eating habits and health, guiding public health strategies and precision nutrition approaches to prevent chronic disease from early life.

Waitlist Available
Has No Placebo

University of New Brunswick

Dr. Maryam Kebbe, PhD, CLC

Have you considered Inveltys clinical trials?

We made a collection of clinical trials featuring Inveltys, we think they might fit your search criteria.
Go to Trials
Image of Department of Nutritional Sciences in Storrs, United States.

Freeze-dried Grape Powder for Healthy Aging

50 - 75
All Sexes
Storrs, CT

The purpose of this study is to investigate the effects of consuming grape powder on immune profiles in healthy middle- and older-aged individuals. Specifically, the investigators are interested in evaluating the potential effects of grapes in influencing markers of immune function, inflammation, and metabolism that are known to change with aging. Grapes contain several nutrients and antioxidant polyphenols such as resveratrol, quercetin, vitamin K and fiber, which are known to promote heart and immune health. However, the effects of grapes on altering immune profiles within the context of aging is not well understood. Therefore, this study will explore how daily grape consumption impacts certain markers of immunity in healthy middle- and older-aged adults. The main study procedures include consumption of a freeze-dried grape powder and control powder (which tastes the same but has none of the grape compounds that are being studied) mixed with water as a beverage on a daily basis for 4 weeks each. The investigators will additionally ask that participants avoid eating grapes and certain other antioxidant/grape-related foods and beverages throughout the 13-week study. Participants will additionally be asked to complete surveys about their diet, physical activity, and medical history, as well as provide blood samples and body weight measures throughout the course of the study. Participation in the study is expected to last about 6.25 hours over the course of 13 weeks and will include 7 visits.

Recruiting
Paid Trial

Department of Nutritional Sciences

Image of Abcentra Investigational Site in Los Angeles, United States.

Orticumab for Heart Attack

18+
All Sexes
Los Angeles, CA

The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies

Phase 2
Recruiting

Abcentra Investigational Site (+6 Sites)

Abcentra

Image of School of Public Health in Bloomington, United States.

High Salt Intake for High Blood Pressure

60 - 85
All Sexes
Bloomington, IN

Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs blood pressure control by affecting systemic blood vessels and the kidneys. These changes contribute to excess salt consumption being associated with increased risk for chronic kidney disease and cardiovascular disease, the leading cause of death in America. Salt is particularly deleterious in older adults who are more likely to exhibit salt-sensitive hypertension. However, salt consumption remains high in the United States. Thus, there is a critical need for strategies to counteract the effects of high dietary salt as consumption is likely not going to decrease. One promising option is ketones, metabolites that are produced in the liver during prolonged exercise and very low-calorie diets. While exercise and low-calorie diets are beneficial, not many people engage in these activities. Limited evidence indicates that ketone supplements improve cardiovascular health in humans. Additionally, published rodent data indicates that ketone supplements prevent high salt-induced increases in blood pressure, blood vessel dysfunction, and kidney injury. Our human pilot data also indicates that high dietary salt reduces intrinsic ketone production, but it is unclear whether ketone supplementation confers humans' protection against high salt similar to rodents. Therefore, the investigators seek to conduct a short-term high-dietary salt study to determine whether ketone supplementation prevents high dietary salt from eliciting increased blood pressure, blood vessel dysfunction, and kidney injury/impaired blood flow. The investigators will also measure inflammatory markers in blood samples and isolate immune cells that control inflammation. Lastly, the investigators will also measure blood ketone concentration and other circulating metabolites that may be altered by high salt, which could facilitate novel therapeutic targets to combat high salt.

Recruiting
Has No Placebo

School of Public Health

Image of Tesla MedBed at Tampa-FL in Tampa, United States.

Biophoton Therapy for Stem Cell Proliferation

18 - 70
All Sexes
Tampa, FL

Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can increase self-grown stem cells naturally. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in impacting stem cells. Approximately 46 volunteers who want to increase self-grown stem cells will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a serial of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants, will be blinded about who received which product during the first two weeks of study participation.

Recruiting
Online Trial

Tesla MedBed at Tampa-FL (+1 Sites)

James Z Liu, MD, PhD

Have you considered Inveltys clinical trials?

We made a collection of clinical trials featuring Inveltys, we think they might fit your search criteria.
Go to Trials
Image of Goldring Center for High Performance Sport in Toronto, Canada.

Physical Activity for Delayed Onset Muscle Soreness

18 - 35
All Sexes
Toronto, Canada

After completing novel activity or exercise we may experience exercise-induced muscle damage (EIMD), resulting in a period of reduced muscle function and delayed onset muscle soreness (DOMS). DOMS is characterized by muscle pain and tenderness that typically resolves within a week. While the precise cause of DOMS is unknown, there is growing evidence implicating damage to the connective tissue that surrounds our muscle fibers and is related to a small amount of inflammation. This inflammation is a normal part of our body's ability to recovery from injuries and may be visualized through the use of ultrasound technology. A variety of recovery techniques have been proposed that may help with the recovery of DOMS such as massage and electrical muscle stimulation, but these are not always accessible. Therefore, we are interested in investigating whether the number of daily steps can affect how you experience DOMS.

Waitlist Available
Has No Placebo

Goldring Center for High Performance Sport

Image of UCSF in San Francisco, United States.

Moisturizers for Aging

65+
All Sexes
San Francisco, CA

This is a randomized, investigator-blinded, self-controlled pilot study of the physiologic response to topical moisturizers among older adults with dry skin. The overarching hypothesis is that skin barrier decline is an important source of chronic inflammation, and that skin barrier restoration with moisturizers can reduce serum biomarkers of inflammation. The primary objective is to determine the feasibility for a larger trial, and the secondary objectives are to determine the extent to which measures of serum inflammation, skin barrier function, and the skin microbiome change in response to moisturizers. Participants will be asked to apply one of two topical moisturizers that are widely available over the counter in the US (Vaseline® 100% pure petroleum jelly or CeraVe® moisturizing cream) once daily for 4 weeks to the front of the torso, buttocks, arms, and legs. Subjects will act as their own control (i.e. they will be asked to apply the study moisturizer they are randomized to for one intervention period (4 weeks) and not to apply topical moisturizers for the other 4- week intervention period). Participants will be randomized in a 1:1:1:1 ratio to one of 4 treatment groups: i. no intervention then CeraVe; ii. CeraVe then no intervention; iii. no intervention then Vaseline; iv. Vaseline then no intervention. At each visit (baseline, week 4, and week 8), participants will undergo skin barrier testing, skin microbiome sampling, and phlebotomy to measure serum inflammatory markers.

Phase 4
Recruiting

UCSF

Katrina Abuabara, MD

Have you considered Inveltys clinical trials?

We made a collection of clinical trials featuring Inveltys, we think they might fit your search criteria.
Go to Trials